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protein kinase (PKA) or protein kinase C (PKC) (Lefkow-
itz, 1993).
The amino acid glutamate (Glu) mediates nearly all
excitatory synaptic transmission in the mammalian brain
by activation of ionotropic glutamate receptors (iGluRs)
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and metabotropic glutamate receptors (mGluRs). There
are currently eight known genes (mGluR1±mGluR8) that
code for mGluRs in the brain (Conn and Pin, 1997). TheseSummary
receptors are differentially expressed throughout the
nervous system and couple to a variety of second mes-Metabotropic glutamate receptors (mGluRs) coupled
senger systems and ion channels to mediate the neuro-to phosphoinositide hydrolysis desensitize in response
modulatory actions of Glu.to prolonged or repeated agonist exposure, and evi-
Group I mGluRs (mGluR1 and mGluR5), which aredence suggests that this involves activation of protein
coupled to stimulation of phosphoinositide (PI) hydroly-kinase C (PKC). The present studies were undertaken
sis, appear to undergo a profound desensitization into determine if cloned mGluR5 undergoes similar PKC-
response to prolonged or repeated agonist exposure.mediated desensitization and to investigate themolec-
Studies have shown that in neuronal cultures, prein-ular mechanism underlying PKC-induced desensitiza-
cubation with various mGluR agonists results in a de-tion. In Xenopus oocytes, both mGluR5a and mGluR5b
creased PI response to subsequent applications ofshowed pronounced desensitization in response to a
mGluR agonists (referred to as desensitization) and thatbrief activation by glutamate. Pharmacological studies
inhibitors of protein kinase C reduce the degree of de-clearly suggest that this desensitization requires PKC-
sensitization (Catania et al., 1991; Aronica et al., 1994).mediated phosphorylation. Analysis of PKC consensus
A number of groups have shown that the PKC activatorphosphorylation site mutants suggests that PKC phos-
phorbol-12,13-dibutyrate (PDBu) induces a desensitiza-phorylates mGluR5 at multiple sites to induce a rela-
tion of group I mGluRs in hippocampal slices, and thistively rapid form of desensitization. Because mGluRs
desensitization is blocked by the PKC inhibitors stauro-play important roles in synaptic plasticity and in excito-
sporine and H-7 (Schoepp and Johnson, 1988; Godfreytoxicity, this desensitization may be involved in the
and Taghavi, 1990). In addition, PKC inhibitors enhancedynamic regulation of these processes.
the maximal PI response elicited by the mGluR agonists
ibotenate and quisqualate (Schoepp and Johnson, 1988;Introduction
Godfrey and Taghavi, 1990). These studies suggest that
mGluRs may exist in a partially desensitized state, atSynaptically releasedneurotransmitter exerts its actions
least in the slice preparations used in these studies.on postsynaptic cells via activation of both ligand-gated
Alternatively, this could be a result of desensitization
ion channels (ionotropic receptors) and on G protein±
that occurs during the prolonged agonist incubations
coupled (metabotropic) receptors. In response to the
used in these studies (30±60 min).
high concentration of neurotransmitter achieved in the
Some data indicate that PI-coupled mGluRs can de-
synaptic cleft, ionotropic receptors undergo desensiti-
sensitize with a more rapid time course. For example, in
zation, an attenuation of receptor responsiveness in the
hippocampal CA3 pyramidal cells, application of mGluR
continued presence of agonist. At some synapses in the
agonists activates a calcium-activated nonselective cat-
brain, ionotropic receptor desensitization is important ion current, ICAN, and this current desensitizescompletelyfor terminating the synaptic response (Trussell et al.,
in approximately 2 min in the continued presence of
1993). Metabotropic receptors can also undergo a form
agonist (Guerineau et al., 1997).A similar rapid desensiti-
of desensitization in response to prolonged agonist acti-
zation of 1S,3R-ACPD-induced depolarization was ob-
vation. Whereas desensitization of ionotropic receptors served in cerebellar Purkinje cells (Glaum et al., 1992).
is generally a kinetic property of the receptor, involving In addition, in cerebrocortical nerve terminals, mGluR-
entry of the channel into a closed state in the presence mediated stimulation of PI hydrolysis (as measured by
of bound agonist (Trussell et al., 1993), the desensitiza- the generation of diacylglycerol) desensitizes by .90%
tion of metabotropic receptors generally involves phos- within 1±2 min of the onset of agonist application (Her-
phorylation of the receptor protein and resultant uncou- rero et al., 1994). This desensitization is prolonged by
pling from signal transduction molecules (Lefkowitz, phosphatase inhibitors and is mimicked by application
1993). Desensitization of metabotropic receptors is of of phorbol esters, suggesting that this rapid desensitiza-
two main types: homologous desensitization, usually tion is mediated by PKC (Herrero et al., 1994).
occurring in response to high concentrations of agonist Consistent with the hypothesis that PKC is involved
and involving receptor phosphorylation by G protein± in mGluR desensitization, in permanently transfected
coupled receptor kinases, and heterologous desensiti- baby hamster kidney cells, rat mGluR1a undergoes
zation, involving phosphorylation by a second messen- PKC-mediated desensitization (Thomsen et al., 1993) as
ger-activated protein kinase such as cAMP-dependent well as rapid (,2 min) agonist-induced phosphorylation
by PKC (Alaluf et al., 1995). PKC-mediated desensitiza-
tion of human mGluR1a has also been reported (Desai²To whom correspondence should be addressed.
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et al., 1995, 1996). Taken together, these data suggest
that desensitization of phospholipase C±coupled mGluRs
may involve PKC-mediated phosphorylation of the re-
ceptor protein. However, no studies to date have ad-
dressed the role of direct phosphorylation of mGluRs
in mediating this agonist-induced desensitization. The
present studies were undertaken to test the hypothesis
that agonist-induced desensitization of mGluR-medi-
ated PI hydrolysis responses involves PKC-mediated
phosphorylation of mGluR5.
Results
Desensitization of mGluR5 in Xenopus
Oocytes Requires Phosphorylation
by Protein Kinase C
In order to determine whether or not mGluR5 can un-
dergo agonist-induced desensitization, mGluR5a and
mGluR5b were expressed in Xenopus laevis oocytes,
and the response to repeated application of Glu was
examined. In Xenopus oocytes, activation of receptors
coupled to phospholipase C (PLC) results in production
of IP3 and diacylglycerol. The elevation of IP3 results in
liberation of Ca21 from intracellular stores and activation Figure 1. Time Course of Recovery from Desensitization for
of an endogenous Ca21-activated Cl2 current. The am- mGluR5a and mGluR5b Expressed in Xenopus Oocytes
plitude of this current is a measure of receptor activity. (A) Shows multiple overlaid pairs of responses from a single oocyte
injected with mGluR5a mRNA to repeated application of 100 mMWhen multiple pulses of Glu (100 mM; 1 min in duration)
Glu (horizontal bars). Between each pair of applications, the oocytewere given to mGluR5-expressing oocytes at various
was allowed to recover for 30 min, and the initial responses followingtime intervals, we observed a profound reduction in the
the 30 min wash are aligned on the left. Scale bars represent 300
amplitude of the second Glu-evoked current as com- nA and 5 min.
pared to the initial response (Figure 1). This reduction (B) Shows the mean 6 SEM amplitude of the current elicited at
in the amplitude of the second Glu-induced current will various time points after the initial 1 min applicationof Glu in oocytes
injected with cRNA coding for mGluR5a and mGluR5b. For eachbe referred to as desensitization and is similar to that
point, n $ 5. The symbol labeled 500 nM Okadaic Acid representsseen in various preparations from rat brain (Glaum et
the mean 6 SEM for four oocytes pretreated for at least 30 minal., 1992; Herrero et al., 1994; Guerineau et al., 1997).
before the initial application of Glu with the 500 nM okadaic acid
Desensitization of mGluR5-induced currents recovered then allowed the full 30 min recovery period in the presence of
slowly over the course of approximately 20±30 min (Fig- okadaic acid, followed by a 1 min application of Glu (n 5 4). Note
ure 1). mGluR5b contains a C-terminal insert of 32 amino that the amplitude of this response was not significantly different
from the response recorded after a 5 min recovery period (p .acids that includes two consensus phosphorylation
0.1, ANOVA). Also shown is the recovery from desensitization timesites (Minakami et al., 1993), allowing for potential dif-
course for the endogenous muscarinic receptor in response to acti-ferences in PKC-mediated phosphorylation and desen-
vation by carbachol (100 mM, 1 min) (5 min, n 5 6; 10 min, n 5 4).
sitization. We found that mGluR5a and mGluR5b de-
sensitized to the same extent and that recovery from
desensitization for the two splice variants occurred over 7.7% (mGluR5a desensitizes by 90.15% 6 1.9%) and
full recovery of the responses occurring in #10 minthe same time course (Figure 1B). These data suggest
that the mGluR5b C-terminal insert does not affect (Figure 1B) (mGluR5a requires 20±30 min for full recov-
ery). Thus, it appears that the profound and prolongedthe course of desensitization of mGluR5-mediated re-
sponses in this system. desensitization of mGluR5-mediated responses is not a
general property of PLC-coupled receptors in oocytesXenopus oocytes can express an endogenous musca-
rinic receptor that also couples to stimulation of PLC. involving modulation of downstream signaling elements
but rather is likely to involve receptor-specific changes.We found the expression of this receptor to be highly
variable, and it was often not detectable. In oocytes As mentioned above, studies in brain slices suggest
that desensitization of group I mGluRs may involve PKCexpressing this receptor, we found that application of
the muscarinic receptor agonist carbachol (100 mM) also phosphorylation, and our initial results suggest that
mGluR5-mediated responses in oocytes desensitize inactivated a Ca21-activated Cl2 current, and this re-
sponse desensitized under the same application proto- a manner similar to that seen in brain. In order to test
the hypothesis that phosphorylation is involved in thecol used for testing mGluR5 desensitization (1 min
agonist, variable wash, 1 min agonist). However, this desensitization of mGluR5 expressed in oocytes, we
tested the ability of okadaic acid, an inhibitor of phos-desensitization was not as extensive or as slow to re-
cover as that of the mGluR5 responses (even in oocytes phatases, to block recovery of mGluR5-mediated re-
sponses from desensitization. In control oocytes, appli-with muscarinic responses .800 nA), with the initial
desensitization after a 5 min wash of only 31.8% 6 cation of Glu (100 mM) 30 min after the initial Glu
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Figure 2. PKC Mediates Desensitization of
mGluR5
(A) Shows the current responses of oocytes
expressing mGluR5a to two applications of
100 mM Glu, separated by a 30 min wash
period. The top trace shows a representative
control recording. The middle shows a repre-
sentative recording from an oocyte treated
for 2 min (from the 14±16 min time points
during washout) with the PKA activator for-
skolin (Fsk, 20 mM). The bottom trace shows
the effect of a similar application of the PKC
activator phorbol-12,13-dibutyrate (PDBu, 10
mM). Scale bar: 400 nA, 5 min.
(B) Shows representative recordings from
control oocytes (top trace), oocytes pre-
treated with the PKA inhibitor H89 (10 mM,
middle trace), and oocytes pretreated with the PKC inhibitor chelerythrine chloride (20 mM, bottom trace). The experimental protocol was 1
min 100 mM Glu (horizontal bars), 5 min washout, 1 min 100 mM Glu, with pretreatment by the inhibitors for at least 20 min. Scale bar: 400
nA, 2 min.
(C) Shows the mean 6 SEM amplitude of the response to the second application of Glu as a percentage of the amplitude of the response to
the first application of Glu. n 5 4 (control, chelerythrine), n 5 5 (H89), and n 5 7 (H7). Asterisk, p , 0.001, ANOVA.
application generated a current that was on average 2C). These data clearly suggest that PKC phosphoryla-
tion is required for desensitization of mGluR5-mediatedequal in amplitude to the initial control current (Figure
responses in oocytes.1). However, if the oocytes were treated with okadaic
It was of interest to determine if activation of PKC byacid (500 nM) prior to and during the first Glu application
other receptors could induce heterologous desensitiza-and throughout the wash period, the second application
tion of mGluR5. In order to address this question, weof Glu (30 min after the initial application) generated a
tested whether activation of the endogenous muscariniccurrent roughly equal in amplitude to that seen after
receptor in oocytes could induce desensitization ofonly 5 min of washout. This suggests that the mGluR5-
mGluR5-mediated responses. Although the endogenousmediated responses did not recover from desensitiza-
muscarinic response recovered from desensitizationtion over the 30 min washout period (Figure 1B; n 5 4).
fully in ,10 min (see Figure 1), we found that activationIn oocytes similarly treated with 1-Nor-okadaone (500
of muscarinic receptors was able to induce desensitiza-nM), an inactive analog of okadaic acid, the response
tion of mGluR5a-mediated responses for .15 min. Thus,after the 30 min wash was not reduced compared to
if a muscarinic response was elicited midway throughthe control current (n 5 4, p . 0.1, ANOVA; data not
a 30 min wash between two Glu applications, the secondshown).
Glu response was only 34.4% 6 6.9% of the first re-The finding that the phosphatase inhibitor prevents
sponse (n 5 5), in contrast to a 97.4% 6 17.6% recoveryrecovery from desensitization clearly suggests that a
in the absence of muscarinic activation (n 5 6). Thisphosphorylation event is involved in the desensitization
finding suggests that agonist activation of mGluR5 isof mGluR5-activated currents observed in oocytes. If
not necessary for PKC-mediated desensitization of thisthis phosphorylation is mediated by PKC, as predicted
receptor and further suggests that any manipulation thatfrom studies in othercells, then activators of PKC should
elevates PKC activity will be likely to result in a reductioninduce desensitization, whereas inhibitors of PKC should
in mGluR5 function.block desensitization. As can be seen from Figure 2, if
two pulses of 100 mM Glu were given 30 min apart, the
second response was roughly equal in amplitude to the Analysis of Point Mutants Suggests mGluR5
first. If, however, a 2 min application of the PKC-activat- Desensitization May Require PKC
ing phorbol ester PDBu (10 mM) was given midway Phosphorylation on Multiple
through the washout period, the response at 30 min was Ser/Thr Residues
completely blocked (Figure 2A; n 5 4). With extensive The results presented above demonstrate that PKC-medi-
washing (.45 min), subsequent mGluR5-mediated re- ated phosphorylation is required for agonist-induced
sponses could be elicited (data not shown). Further- desensitization of mGluR5-mediated currents in oocytes.
more, preincubation of oocytes with chelerythrine, a One obvious potential target for this PKC-mediated
specific inhibitor of PKC, or H7, a general protein kinase phosphorylation is mGluR5 itself, but there are several
inhibitor, greatly reduced desensitization (Figures 2B other potential sites for this phosphorylation, including
and 2C). Direct activation of PKA by forskolin (25 mM) the Ca21-activated Cl2 channel, PLC, enzymes involved
had no significant effect on subsequent responses in the inositol phosphate signaling pathway, and G pro-
(mean 6 SEM for forskolin 5 92% 6 5.7%, n 5 4; teins. The fact that the endogenous muscarinic receptor
control 5 95.9% 6 12.7%, n 5 6; see Figure 2A). H89, a responses recover from desensitization much more
compound that is structurally related to H7 buta specific quickly than the mGluR5-mediated responses reduces
inhibitor of PKA,did not significantly reduce the desensi- the likelihood that this phosphorylation occurs solely in
the signal transduction pathway. Consistent with thetization of mGluR5-induced currents (Figures 2B and
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Figure 3. Desensitization Properties of mGlu-
R5a PKC Consensus Site Mutants
(A) Shows the responses of oocytes express-
ing mGluR5a or different PKC site mutants to
two consecutive 1 min applications of 100
mM Glu (horizontal bars), separated by a 5
min washout (same protocol as forFigure 2B).
Scale bar is 600 nA, 2 min.
(B) Shows the mean 6 SEM amplitude of the
response to the second application of Glu as
a percentage of the amplitude of the re-
sponse to the first application of Glu (n $ 5).
Each clone was recorded from oocytes taken
from at least two different frogs on different
days and always accompanied by wild-type
recordings on the same day. Asterisk, p ,
0.05, ANOVA. See Experimental Procedures
for each of the individual amino acid changes
made.
hypothesis that mGluR5 itself may be the target of PKC the degree of desensitization, the decay of the peak
current during Glu application was significantly slowerphosphorylation, one previous study has shown that
phorbol esters induce phosphorylation of mGluR5 ex- than for the wild-type receptor, whereas mutations hav-
ing no effect on desensitization had the same decaypressed in NIH3T3 cells and HEK293 cells (Kawabata
et al., 1996). In order to test the hypothesis that the kinetics on average as wild-type mGluR5a (Figure 4).
This broadening of responses was also observed in oo-desensitization of mGluR5 observed in oocytes could
be mediated by PKC-induced phosphorylation of mGluR5, cytes incubated with the PKC inhibitor chelerythrine but
not in oocytes treated with the PKA inhibitor H89 (Fig-we constructed mutant receptors in which various PKC
consensus phosphorylation sites were knocked out by ures 4B and 4C). The finding that the PKC consensus
site mutants have the same effect as the PKC inhibitormutating codons coding for Ser orThr in PKC consensus
sites to neutral amino acids. Based on a thorough char- on current decay rates is consistent with the idea that
the mGluR5-mediated responses undergo PKC-medi-acterization of PKC consensus sequences (Pearson and
Kemp, 1991) and the published sequence for mGluR5a ated desensitization during the 1 min exposure to ago-
nist and that the desensitization may be mediated by(Abe et al., 1992), 24 such PKC consensus phosphoryla-
tion sites were found on regions predicted to be intracel- phosphorylation on sites T606, S613, T665, S881, and
S890 or some combination of these sites.lular in mGluR5a. Each of these 24 consensus sites was
individually mutated to a neutral amino acid. Glu (100 If these mutations in PKC consensus sites are in fact
reducing desensitization by preventing phosphorylationmM) was applied to oocytes for 1 min (control) followed
by a 5 min washout period after which a second identical by PKC, then one would predict that these mutations
should reduce the inhibition of mGluR5 responses byGlu application was made (test). The amplitude of the
test current was 9.87% 6 2.2% of the control current PKC activators. In order to test this hypothesis, we ex-
amined the ability of a submaximal dose of phorbolamplitude for wild-type mGluR5a (n 5 25), a desensitiza-
tion of roughly 90%. Compared to the wild type, no esters to inhibit the function of wild-type mGluR5 and
the PKC site mutants that reduced desensitization. Ansignificant differences in the amplitude of the test cur-
rent relative to the control current were found for 19 of initial control current was recorded (100 mM Glu, 1 min)
after which the oocyte was removed from the recordingthe 24 PKC consensus site mutants tested. We found
that for five of the PKC consensus site mutants, T606A, chamber and placed in a dish containing normal Barth's
solution for 30 min. Following this wash period, the oo-S613G, T665V, S881A, and S890G, this desensitization
was significantly reduced (Figure 3). Thus, for T606A, cyte was returned to the recording chamber and bathed
for 2 min in control Barth's solution or Barth's containingthe test current was 23.9% 6 4.2% of control (n 5 10);
for S613G, 47.3% 6 6.9% of control (n 5 14); for T665V, the PKC-activating phorbol ester phorbol-12-myristate-
13-acetate (PMA, 100 nM) or its inactive form, 4aPMA45.6% 6 6.1% of control (n 5 10); for S881A, 75.1% 6
13.1% of control (n 5 11); and for S890G, 63.2% 6 5.4% (200 nM), after which a test current was recorded. Fol-
lowing treatment of wild-type mGluR5a with control so-of control (n 5 18).
Interestingly, we found that the reduction in desensiti- lution or the inactive 4aPMA, the amplitude of the test
current was not significantly reduced as compared tozation of the PKC site mutants was reflected not only
in the reduced response to multiple applications of Glu the control current amplitude (p . 0.1, ANOVA). How-
ever, following treatment with the active PMA, mGluR5abut also in the kinetics of the response to a single Glu
application. Thus, for each of the mutants that reduced currents were inhibited by z75% (Table 1). For each of
PKC-Mediated Desensitization of mGluR5
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Figure 4. Kinetics of Current Decay Rates in
the Presence of Glu for Wild-Type mGluR5a
and PKC Consensus Site Mutants
(A) Representative traces showing the slowed
current decay rate during Glu application for
the S890G mutant as compared to wild type
(wt).
(B and C) Detailed kinetic analysis was per-
formed on wild-type control oocytes (n 5 15),
oocytes treated with the PKC inhibitor cheler-
ythrine chloride (20 mM; n 5 6), oocytes
treated with the PKA inhibitor H89 (10 mM,
n 5 4), and various PKC consensus site mu-
tants (n $ 5). Currents were fitted to two ex-
ponentials, and the data shown represent the
mean 6 SEM time constant for the decay of
the Glu-evoked current that occurred during a 1 min application of 100 mM Glu. The S612G and T891G mutants are shown for comparison
as mutations that had no effect on desensitization measured as in Figure 3 but are immediately adjacent to mutations that reduced desensitiza-
tion. Asterisk, p , 0.05, ANOVA.
the PKC consensus site mutants that reduced mGluR5 in oocytes or the protein for these mutants is not reach-
ing the cell surface.desensitization, we found that the percent inhibition by
Because none of the mutations tested individuallyPMA was significantly smaller than thepercent inhibition
completely block desensitization of mGluR5-mediatedof wild-type mGluR5a (p , 0.05, ANOVA; Table 1).
responses in oocytes, it was of interest to know if com-In addition to the effects of the above mentioned mu-
bining the mutations could completely block desensiti-tations, several point mutants resulted in a decrease in
zation. We constructed a mutant receptor in which allor loss of mGluR5 coupling to PLC. Thus, the mutation
five sites that were found to be involved in desensitiza-T681A resulted in a total loss of PLC coupling (Figure
tion were changed to neutral amino acids. We found5). The double mutant S612G/S613G also resulted in
a complete loss of PLC coupling in oocytes, whereas
individual mutations of S612G and S613G functioned
normally with the exception that S613G dramatically
reduced desensitization, as mentioned above (see Fig-
ure 3). Finally, the point mutant S881A showed markedly
reduced currents, which were much slower in reaching
peak amplitude as compared to wild type (Figure 5),
although injection of increased amounts of RNA allowed
for recording of responses large enough to measure
desensitization properties accurately (see Figure 3). Al-
though no currents could be recorded from oocytes
injected with S612G/S613G or T681A RNA, the RNA was
of the appropriate size, as determined by agarose gel
electrophoresis (data not shown), and Western blot anal-
ysis of oocytes injected with this RNA showed protein
levels within the normal range (Figure 5B). Thus, it is
clear that either the receptors are not coupling to PLC
Table 1. Effects of Phorbol Esters on the Amplitude
of Glu-Evoked Currents in Oocytes Injected with RNA
for mGluR5a or PKC Site Mutants
Figure 5. Some PKC Consensus Site Mutants Resulted in a Loss
% Inhibition of Coupling to PLC in Oocytes
Clone Treatment (mean 6 SEM) n
(A) The left trace shows a typical current elicited by application of
mGluR5a None 22.6 6 17.6* 6 100 mM Glu to an oocyte expressing wild-type (wt) mGluR5a. The
mGluR5a 4aPMA, 200 nM 5.3 6 15.6* 6 traces on the right are representative traces recorded from oocytes
mGluR5a PMA, 100 nM 75.1 6 6.5 9 injected with cRNA coding for the double mutant S612G/S613G and
T606A PMA, 100 nM 37.0 6 10.1* 5 the point mutants T681A and S881A. Scale bars represent 0.5 mA,
S613G PMA, 100 nM 42.8 6 11.7* 6 1 min. The average current recorded from S881A was 182.4 6
T665V PMA, 100 nM 30.3 6 14.7* 8 54.7 nA compared to wild-type currents, which were on average
S881A PMA, 100 nM 29.7 6 14.1* 4 1089.7 6 93.3 nA on the same days (mean 6 SEM). n $ 6 for
S890G PMA, 100 nM 12.9 6 6.8* 4 the loss-of-function mutants, each taken from multiple clones and
recorded from oocytes taken from at least two different frogs.Values represent the inhibition of Glu-evoked currents recorded 30
(B) Western blot analysis showing relative expression level ofmin after a control current and immediately after a 2 min exposure
mGluR5a wild type, S612G/S613G, T681A, and S881A. In this blot,to PMA or its inactive form, 4aPMA. Asterisk, p , 0.05, ANOVA
each lane was loaded with protein equivalent to 1/10 of an oocyte.versus mGluR5a treated with PMA.
This blot is representative of four experiments.
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Discussion
Figure 7 shows the proposed topological profile for
mGluR5 and the position of each of the point mutations
made in this study. From this figure, one can see that
the mutations with functional consequences in terms of
PLC coupling appear to be grouped into three relatively
small regions of the protein: the proposed first and sec-
ond intracellular loops and a relatively restricted proxi-
mal portion of the C-terminal intracellular tail. Heterolo-
gous desensitization of the b2-adrenergic receptor
involves PKA-mediated phosphorylation of the receptor
on the C-terminal tail and on the third intracellular loop,
resulting in uncoupling of the receptor from the G protein
(Hausdorff et al., 1990). Desensitization of mGluR5 also
appears to involve phosphorylation of the receptor on
multiple intracellular domains and shares with the b2-
adrenergic receptor the fact that the C-terminal tail is
one of these domains. In contrast, the third intracellular
loop of mGluR5 does not appear to be involved in desen-
Figure 6. Lack of Desensitization in a Mutant Combining all Five
sitization of mGluR5, but the first and second intracellu-Sites Found to Be Involved in mGluR5 Desensitization
lar loops do contain sites critical to this process. TheThe traces in the top panel show representative recordings from
finding that mutations in these regions have variousoocytes expressing the multiple site mutant T606A/S613G/T665V/
effects on mGluR5 coupling to G proteins is consistentS881A/S890G or low levels of wild-type mGluR5a or S890G. Scale
bar is 150 nA, 3 min. The bar graph shows the mean 6 SEM percent with a recent report that provided evidence that these
desensitization of Glu-evoked currents (100[1 2 second response regions are critical domains for defining the specificity
amplitude/first response amplitude]). The experimental protocol of G protein coupling of mGluRs (Gomeza et al., 1996).
was identical to that in Figure 3. n 5 7 (wild type), 3 (S890G), and
The PKC-mediated desensitization of mGluR5 re-10 (T606A/S613G/T665V/S881A/S890G). Asterisk, p , 0.05, ANOVA
ported here represents the classical feedback loop formversus mGluR5a; double asterisks, p , 0.01 compared to mGluR5a
of desensitization in which the result of receptor activa-and S890G.
tion, elevation of intracellular calcium and activation of
PKC, results in a termination of the response. Consistent
with the idea that this represents heterologous desensi-that in this multiple mutant (T606A/S613G/T665V/
tization, we found that activation of PKC by phorbolS881A/S890G), desensitization measured at the 5 min
esters or by activation of muscarinic receptors can in-time point was completely abolished (Figure 6). Activa-
duce desensitization of mGluR5 in the absence of ago-tion of this receptor by 100 mM Glu induced currents
nist activation (Figure 2; Table 1). There is no evidencethat were smaller than wild-type mGluR5a, as was the
to date from studies in brain or expression systems thatcase for the S881A mutant alone. However, oocytes
group I mGluRs undergo homologous desensitizationÐexpressing lower levels of wild type and S890G (currents
that is, desensitization induced by phosphorylation me-,600 nA) desensitized to the same extent as those ex-
diated by G protein±coupled receptor kinases in re-pressing higher levels of protein. Thus, combining all of
sponse to agonist occupation of the receptor.the functionally relevant sites serves to abolish com-
The data presented here are consistent with the cur-pletely desensitization of mGluR5-mediated responses
in oocytes. rent topological model of mGluR5 (Abe et al., 1992).
Figure 7. Proposed Topological Model of
mGluR5 Showing Sites Involved in PKC-Me-
diated Desensitization
All PKC consensus site mutations made are
indicated. The sites for which mutation to a
neutral amino acid resulted in a decrease in
desensitization are indicated by bold italic
type and closed circles. The italic type and
asterisks indicate the mutants for which mu-
tation to a neutral amino acid resulted in a
loss of or decrease in PLC coupling. Sites for
which mutation to neutral amino acid had no
effect are indicated by the closed triangles.
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Although no mutations of Ser or Thr residues in pro- activation of #1 min. These findings are consistent with
one report showing that PKC-mediated desensitizationposed extracellular domains were made, the mutations
that had functional effects place the regions between of PLC-coupled mGluRs in cortical synaptosomes can
occur during 1±2 min of agonist exposure (Herrero etthe first and second hydrophobic domains as well as
that between the third and fourth hydrophobic domains al., 1994). Thus, desensitization of mGluR5 may play
important roles in regulating synaptic transmission andand the region downstream of the seventh hydrophobic
domain inside the cell. There is no evidence here to plasticity under normal conditions rather than requiring
large and prolonged increases in Glu in the brain.address the topological arrangement of the regions be-
tween the fourth and seventh hydrophobic domains. Activation of group I mGluRs is known to have many
excitatory actions in the brain (Conn and Pin, 1997).A previous report indicated that phorbol esters can in-
duce phosphorylation of mGluR5 expressed in NIH3T3 Take for example the effects of activation of group I
mGluRs in area CA1 of the rat hippocampus. Applicationcells and specifically that mGluR5 can be phosphorylated
on T840 (Kawabata et al., 1996). The authors proposed of group I mGluR agonists has a variety of excitatory
actions in area CA1, including action potential broaden-that phosphorylation of T840 on mGluR5 mediates the
oscillatory nature of mGluR5a-induced elevations of ing, depolarization of CA1 pyramidal cells, blockade of
synaptic inhibition, potentiation of NMDA receptor re-intracellular Ca21 in HEK293 cells and NIH3T3 cells. In-
terestingly, we found that the mutant T840G had no sponses, and a reduction in the afterhyperpolarization
current, which serves to limit repetitive action potentialfunctional effects in terms of desensitization of mGluR5-
mediated responses in oocytes in response to prolonged firing (Aniksztejn et al., 1991; Desai et al., 1991; Hu and
Storm, 1992; Gereau and Conn, 1995a, 1995b). Becauseor repeated agonist exposure (see Figures 3, 4B, and
4C). The fact that we did not see a functional effect all of these actions serve to increase excitability of CA1
pyramidal cells, prolonged activation of mGluR5 in thisof this mutation does not indicate that the site is not
phosphorylated but rather that phosphorylation of this region could contribute to excitotoxic cell damage.
Thus, desensitization of group I mGluRs could serve tosite is not important for desensitization of the receptor
in oocytes. limit these excitatory actions during pathological states
such as epilepsy and stroke, which result in an increaseIn the present study, we have shown that desensitiza-
tion of mGluR5-mediated responses inXenopus oocytes in Glu levels in the brain. The excitatory actions of
mGluR5 activation could also contribute to the inductionrequires phosphorylation by PKC. In addition, mutating
five of the PKC consensus sites results in a decrease of synaptic plasticity in this region. Indeed, long-term
potentiation in the CA1 region is reduced by geneticin this PKC-mediated desensitization. One obvious in-
terpretation of these data is that mGluR5 is phosphory- disruption of the mGluR5 gene in mice, and this effect
is accompanied by deficits in learning (Lu et al., 1997).lated on these sites and that this phosphorylation dis-
rupts normal G protein coupling. However, it is formally Therefore, desensitization of mGluR5 could also be in-
volved in regulation of these processes. Further studiespossible that mutating these sites does not blockdesen-
sitization by blocking phosphorylation of mGluR5 but will be needed to determine if PKC-mediated desen-
sitization of mGluR5 plays a role in limiting injury inby disrupting an interaction of mGluR5 with another
protein that is itself regulated by PKC. For example, if pathological conditions and in regulation of learning and
memory.mGluR5 interacts with multiple signaling pathways via
G proteins, it is possible that mutation of certain amino
acids could disrupt coupling to one G protein without Experimental Procedures
affecting coupling to another. Thus, if mGluR5 couples
Materialsto both a G protein that stimulates PLC and one that
Xenopus were purchased from Nasco. The mGluR5a and mGluR5binhibits PLC, then blocking coupling to the inhibitory G
pBluescript SK(2) constructs were generously provided by Dr. Jean-protein could disrupt desensitization. It is also possible
Philippe Pin. The polyclonal mGluR5 antibody was obtained from
that mGluR5 is associated with other proteins that could Upstate Biotechnology (Lake Placid, NY). Pfu polymerase was ob-
regulate mGluR5 signaling. One recent study has shown tained from Stratagene (La Jolla, CA). H89, H7, and okadaic acid
that a novel protein,Homer, interacts with the C-terminal were obtained from Biomol. Chelerythrine chloride, PMA, 4aPMA,
and PDBu were obtained from Research Biochemicals. 1-Nor-oka-domain of PLC-coupled mGluRs (Brakeman et al., 1997).
daone was purchased from Alexis Biochemicals (San Diego, CA).While this protein interacts with the C-terminal residues
Restriction enzymes were obtained from New England Biolabs andof mGluR1 and mGluR5, it is conceivable that mutations
Boehringer Mannheim. All other materials were obtained from Sigmain other regions of the protein could disrupt an interac-
(St. Louis).
tion with Homer or another mGluR5-associated protein.
Most prior reports of desensitization of mGluR-medi-
Xenopus Oocyte Recordings
ated responses have focused on the effects of prolonged Female Xenopus were anesthetized using tricane. The ovaries were
exposure of neuronal cultures, brain slices, or cells ex- exposed, and several lobes of oocytes were removed and cut into
pressing mGluRs to agonists (Schoepp and Johnson, smaller pieces. The oocytes were then defolliculated by an z1 hr
collagenase (Worthington) treatment in calcium-free Barth's solu-1988; Godfrey and Taghavi, 1990; Catania et al., 1991;
tion. Oocytes were maintained at 168C in Barth's solution (88 mMThomsen et al., 1993; Aronica et al., 1994). While the
NaCl, 1.1 mM KCl, 2.4 mM NaHCO3, 0.3 mM Ca(NO)3, 0.3 mM CaCl2,effect is clear, the physiological relevance of agonist
0.8 mM MgCl2, 15 mM HEPES).treatment for 30 min to several hours is questionable. Twelve to seventy-eight hours following cRNA injection, oocytes
The present study indicates that desensitization of were placed individually in a recording chamber and perfused at a
mGluR5 can occur on a much more rapid time scale, rate of z3 ml/min with Barth's solution. Two-electrode voltage-
clamp recordings were performed using an Axoclamp 2A (Axonwith marked desensitization occurring during an agonist
Neuron
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Instruments). Cells were voltage clamped at 260 mV, and data were National Institutes of Health (R. W. G. and S. F. H.) and a grant from
the McKnight Foundation (S. F. H.).digitized and written directly to a computer hard drive for off-line
analysis using Axotape 2 software (Axon Instruments). Kinetic analy-
sis of the responses was carried out using the N05 software, gen-
Received September 2, 1997; revised October 22, 1997.erously provided by Dr. Stephen F. Traynelis (Emory University,
Atlanta).
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